The Food and Drug Administration has approved a drug that reduces the chances of contracting HIV. A University of Utah ...

Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be ...

Once both molecules of the virus are bound to the cell membrane, the process of injecting viral RNA can begin. “Because HIV-1 is an integrating virus, blocking this process completely is essential to ...

The authors concluded in their paper, “ … our cryo-EM structure indicates that PR can form dimers while part of Pol … Together, our results show how HIV-1 maturation leverages the ...

In a study of human immune cells infected with HIV, the virus that causes AIDS, scientists at Johns Hopkins Medicine say a ...

A team of scientists at the Helmholtz Institute for RNA-based Infection Research (HIRI) in Würzburg and the University of Regensburg has unveiled insights into how HIV-1, the virus responsible ...

Once researchers were able to create a stable version of HIV Pol, the Salk team used cryogenic electron microscopy to reveal the three-dimensional structure of the HIV Pol protein molecule.

The moving structure they found protects the sensitive co-receptor binding site on the virus. "It's also a latch to keep it from springing until it's ready to spring," Henderson said.

Current studies focus on various animal and bacterial viruses, including the human immunodeficiency (HIV) virus, parvoviruses and several viruses that cause colds in humans. In 1985, his group became ...

Sundquist’s research focuses on understanding how the HIV virus is built on a molecular level and how it interacts with the body to infect and spread through cells. By purifying and analyzing the ...